BCL2L1 and non-Hodgkin lymphoma: Using highly potent and selective inhibitors of BCL-2,(ref. 20) BCL-XL(ref. 31) or MCL-1,(refs 27, 28, 32) and combinations thereof, we sought to further classify the survival dependency of NHL for anti-apoptotic BCL-2 family members.